GlassScriptPhysician profile
Wendi Johnson
NPI 1477950566
$1,595.29
in general payments reported to CMS, 2019-2025
20 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $325 · 2022: $597 · 2023: $282 · 2024: $252 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $351.74 | 2021-2025 | Injectafer |
| Astellas Pharma US INC | $326.50 | 2022-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $152.84 | 2021-2025 | |
| Abbvie INC. | $149.05 | 2021-2024 | |
| Myriad Women'S Health, INC. | $113.15 | 2023 | Myrisk |
| Millicent US INC | $75.92 | 2024-2025 | Femlyv, Intrarosa |
| Myovant Sciences INC. | $67.37 | 2022 | |
| Mylan Pharmaceuticals INC. | $65.62 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.13 | 2022-2023 | |
| Therapeuticsmd, INC. | $43.62 | 2021-2022 | |
| Scynexis, INC. | $38.06 | 2022 | |
| Sage Therapeutics, LLC | $28.09 | 2021-2022 | |
| Novo Nordisk INC | $23.28 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $19.85 | 2023 | Vivjoa |
| Exeltis, USA INC. | $17.93 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $16.85 | 2022 | |
| Agile Therapeutics, INC. | $14.93 | 2022 | |
| Guard Medical INC. | $14.36 | 2024 | Npseal Large |
| Kowa Pharmaceuticals America, INC. | $12.79 | 2023 | Seglentis |
| Ascend Therapeutics US, LLC | $12.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendi Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.